Bei Akademie registrieren
Amgen, US0311621009

Amgen reports Tezspire trial results. Amgen stock trades EUR 392.10

Published on 10/24/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock trades at EUR 392.10 in weekend trading on October 24, 2026. Amgen reported week-52 Tezspire results on October 20.

Clinical data and trading dates

  • Amgen reported October 20, 2026, that week-24 histologic remission reached 64.8 percent and 68.9 percent for the two Tezspire doses.
  • Amgen stock trades in weekend trading at Lang & Schwarz at EUR 392.10 at 10:39 a.m. CEST on October 24, 2026.
  • The next Xetra session is scheduled for October 26, 2026.
Architektonischer 3D-Render eines modernen Biopharma-Gebäudes mit Glasfassade und gepflegter Grünanlage
Amgen Inc. (ISIN US0311621009) passend visualisiert als architektonischer Render einer modernen Biopharma-Forschungsanlage, Illustration mit AI erstellt.

On October 20, 2026, Amgen and AstraZeneca reported full results from the Phase 3 CROSSING trial of TEZSPIRE in eosinophilic esophagitis. Histologic remission at week 24 was reported for 64.8 percent of patients receiving the 210-milligram dose and 68.9 percent receiving the 420-milligram dose, compared with 3.5 percent for placebo. Amgen stock trades at EUR 392.10 in weekend trading at Lang & Schwarz on October 24, 2026, with the timestamp at 10:39 a.m. CEST.

Market context: Market report S&P 500.

The week in figures

Lang & Schwarz showed Amgen at EUR 392.10 in weekend trading on October 24, 2026. The bid was EUR 391.70 and the ask was EUR 392.50.

The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Amgen stock.

Chronology of the week

On October 20, 2026, Amgen and AstraZeneca announced results from the CROSSING trial. The study reported week-52 histologic remission rates of 67.8 percent for the 210-milligram dose and 63.3 percent for the 420-milligram dose, compared with 5.4 percent for placebo, according to Amgen.

Also on October 20, 2026, Amgen said it would host a webcast on its oncology portfolio and selected data presented at the European Society of Medical Oncology Congress 2026. The webcast was scheduled for October 24, 2026, at 11:30 a.m. Pacific Time, according to Amgen.

Dates of the coming week

The next Xetra session is scheduled for October 26, 2026. No forecast is implied by the calendar date.

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70403759 | bgmi